IPO点评：瀚天天成

Investment Rating - The report assigns an IPO-specific rating of 4.9 out of 10 for the company, based on operational performance, industry outlook, valuation, and market sentiment [7]. Core Insights - The company is a global leader in the silicon carbide epitaxy industry, focusing on the research, production, and sales of silicon carbide epitaxial wafers, which are used in power device manufacturing for sectors such as electric vehicles, charging infrastructure, renewable energy, and energy storage [1]. - The company is expected to maintain its position as the largest supplier of silicon carbide epitaxial wafers, with a projected market share exceeding 30% in 2024 [1]. - Financial projections indicate a peak in revenue in 2023, followed by a decline in 2024 and 2025 due to industry destocking, price reductions, and weakened downstream demand [1][2]. Company Overview - The company serves 134 clients, including four of the top five global silicon carbide power device manufacturers [1]. - Revenue figures for 2022-2024 are projected at 4.41 billion, 11.4 billion, and 9.74 billion, respectively, with a net profit of 1.28 billion, 1.08 billion, and 1.65 billion for the same years [1]. - The company employs a dual model of epitaxial wafer sales and wafer foundry services, with wafer sales being the primary revenue source [1]. Industry Status and Outlook - The global silicon carbide power device market is expected to reach $2.6 billion in 2024, with a compound annual growth rate (CAGR) of 39.9% from 2024 to 2029, potentially reaching $13.6 billion by 2029 [2]. - The semiconductor industry is currently undergoing an inventory adjustment cycle, which is expected to conclude in the second half of 2026, indicating a cyclical rather than structural downturn [2]. Strengths and Opportunities - The company has significant technical barriers, with its founder being the first IEEE fellow in the silicon carbide field and over 35 years of research experience [3]. - The company has achieved a leading market position, being the first globally to mass-produce 8-inch products and planning to launch 12-inch silicon carbide epitaxial wafers by December 2025 [3]. - The end of the inventory cycle in 2026 is anticipated to lead to a recovery in demand, benefiting from new applications in home appliances, AI computing, and energy storage [3]. Weaknesses and Risks - Revenue is projected to decline by 14.7% in 2024 compared to 2023, with a continued decrease in gross margin expected [4]. - The company has a high customer concentration, with over 60% of revenue coming from its top five clients [4]. - There are risks associated with industry competition and potential prolonged inventory adjustments, which could impact profitability [4]. IPO Information - The IPO is scheduled from March 20 to March 25, 2026, with a share price set at HKD 76.26, and trading is expected to commence on March 30, 2026 [5]. - The company aims to raise approximately HKD 15.6 billion, with 71% allocated to expanding production capacity for silicon carbide epitaxial wafers [10]. Investment Recommendation - The company is positioned as a dominant player in the silicon carbide epitaxy market, with strong technical and customer advantages, and is expected to benefit from trends in renewable energy and domestic semiconductor production [11]. - The IPO price corresponds to a market capitalization of HKD 32.455 billion, with a price-to-sales ratio of approximately 41.2x, suggesting a cautious approach to subscription [11].